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The U.S. President’s Malaria Initiative
The U.S. President’s Malaria Initiative (PMI) is a U.S. Government 
initiative established in 2005 to decrease malaria deaths by 
scaling up proven interventions in sub-Saharan Africa, where 
malaria exacts its worst toll. Initially targeting 15 countries, 
PMI has now expanded to 19 sub-Saharan Africa countries and 
the Greater Mekong Subregion, where resistance to the most 
effective malaria treatment drugs has already appeared. PMI’s 
goals are ambitious: Cut malaria illnesses and deaths by half 
in 70 percent of at-risk populations in sub-Saharan Africa, i.e., 
approximately 450 million residents. 
CDC and the U.S. Agency for International Development jointly 
implement this initiative; it is led by the U.S. Global Malaria 
Coordinator. PMI is one part of CDC’s global malaria portfolio, 
which also spans policy development, program guidance and 
support, scientific research, and monitoring and evaluating 
progress toward global malaria goals. 
As part of a PMI 
operational research 
study led by CDC, health 
workers test children 
with fever for malaria in 
a busy clinic in Luanda, 
the capital of Angola. 
CDC’s Contributions to PMI 
Scientific leadership. For more than 60 years, CDC has 
provided scientific leadership in public health efforts to fight 
malaria, increasing global understanding and capacity to 
prevent death and illness from malaria, especially among 
those most vulnerable to this disease – pregnant women and 
children. CDC has also helped develop and evaluate four key 
global malaria interventions supported by PMI:
 • Long-lasting insecticide-treated nets (ITNs)
 • Rapid tests to diagnose malaria and artemisinin-based 
combination therapies (ACTs) to treat malaria patients 
 • Intermittent preventive treatment for pregnant women 
(IPTp) 
 • Indoor residual house spraying (IRS)
NMCP collaboration. With PMI, CDC continues its long history 
of collaboration with National Malaria Control Programs 
(NMCPs) to help build their technical leadership and capacity to 
implement effective prevention and control, particularly in the 
following areas:
 • Design and implementation of monitoring & evaluation 
plans
 • Surveillance systems to track progress
 • Operational research to improve implementation
 • Case management (including diagnostics) strengthening
 • Entomology/vector control
 • Laboratory support for ensuring quality nets, drugs, and 
diagnostics
PMI Helps Scale Up Malaria Control Interventions
In the last decade, increased funding by many donors and 
partners supporting malaria prevention and control efforts 
have led to a massive scale-up of malaria interventions. 
In FY 2012 alone, PMI:
 • protected more than 30 million residents by spraying 
more than 7 million houses with insecticides
 • procured more than 21 million long-lasting ITNs
 • procured more than 72 million ACT treatments and more 
than 28 million rapid diagnostic tests
 • procured more than 4 million sulfadoxine-pyrimethamine 
treatments for intermittent preventive treatment for 
pregnant women.
PMI has also supported training thousands of health workers 
in IPTp, treatment with ACTs, and laboratory diagnosis. PMI has 
also supported strengthening pharmaceutical management, 
laboratory diagnosis, insecticide and drug resistance 
surveillance, and monitoring and evaluation.
Mali
Congo, DRC
Angola
Ethiopia
Nigeria
Tanzania
Zambia
Kenya
Zimbabwe
Guinea
Mozambique
Madagascar
Ghana
Uganda
Senegal
Benin
Malawi
Liberia
Rwanda
Legend
Pyrethroid Resistance 2012
Non-PMI
No data
No resistance
Emerging resistance
Resistance
Mali
Congo, DRC
Angola
Ethiopia
Nigeria
Tanzania
Zambia
Kenya
Zimbabwe
Guinea
Mozambique
Madagascar
Ghana
Uganda
Senegal
Benin
Malawi
Liberia
Rwanda
Legend
Pyrethroid Resistance 2009
Non-PMI
No data
No resistance
Emerging resistance
Resistance
ITNs and IRS rely partially or completely on insecticides to prevent malaria 
transmission, and PMI monitors mosquitoes’ resistance to these insecticides to 
ensure that they remain effective at killing malaria-infected mosquitoes. This 
resistance information guides the insecticide choice for IRS and the strategy for its 
use. In the maps to the left, mosquitoes in some sites in countries colored red have 
shown resistance to pyrethroids, the only class of insecticide that can be used in ITNs 
and a frequent choice for IRS.
CDC’s Congressional Mandate in Support of PMI
CDC is charged by U.S. Congress (through the Lantos-Hyde 
Act, 2008) to take a leading role in strategic information 
(monitoring and evaluation, surveillance, operations 
research)—advising the U.S. Malaria Coordinator on priorities 
for these activities and being a key implementer. To ensure 
that limited resources are being used wisely, CDC helps 
countries and the U.S. Government target appropriate malaria 
prevention and treatment efforts and understand the impact 
of PMI efforts. 
Evidence of Malaria Intervention Impact 
More people than ever have access to life-saving malaria 
interventions, and WHO’s World Malaria Report 2012 reports 
that globally more than a million lives have been saved. The 
number of people becoming sick or dying from malaria has 
decreased by 25% globally and by 33% in sub-Saharan Africa. 
Twelve of the 15 original PMI target countries with data from 
two or more nationwide surveys conducted since PMI began 
show declines in deaths of children under five years of age. 
The declines range from 16 percent in Malawi to 50 percent in 
Rwanda. A careful examination of these declines in all-cause 
mortality in both mainland Tanzania and Malawi found strong 
evidence that malaria interventions played a major role in 
these decreases in deaths. PMI is in the midst of conducting 
other extensive impact evaluations in target countries.
PMI at Work in Target Countries
PMI efforts in each country are coordinated by two PMI 
resident advisors (one CDC advisor and one USAID advisor), 
who are supported by other in-country staff and by country 
teams at headquarters (CDC/Atlanta and USAID/Washington). 
These teams work with host country governments to support 
the implementation of the national malaria control programs’ 
plans. The PMI teams develop annual malaria operational 
plans; participate in national malaria partner coordination 
mechanisms; and design, implement, monitor, and evaluate 
program activities. 
Partnership Is Key
PMI works in partnership with host country governments 
in Africa and supports and builds on their national malaria 
control program plans. CDC, USAID, and other U.S. Government 
agencies work with the Global Fund to Fight AIDS, TB, and 
Malaria; Roll Back Malaria; U.K. Department for International 
Development; UNICEF; the World Bank; the World Health 
Organization; bilateral donors; and other organizations in 
supporting host countries’ malaria control efforts. PMI also 
works with nongovernmental organizations, including faith-
based and community groups, academia, and the private 
sector. With these partnerships, PMI helps identify and fill 
programmatic and resource gaps to reduce illness and deaths 
caused by malaria.
For more information on PMI, see  
www.pmi.gov.  
For more  
information on CDC’s malaria program, see 
www.cdc.gov/malaria
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